Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiupeng Wang

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|January 12, 2026
Mesoporous Silica: A Promising Adjuvant for Cancer VaccinesXiupeng Wang
Nanomaterials (Basel, Switzerland)|December 22, 2023
An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for ChemoimmunotherapyXinyuan Yuan, Xiupeng Wang
Journal of Materials Science. Materials in Medicine|August 19, 2007
Variation of crystal structure of hydroxyapatite in calcium phosphate cement by the substitution of strontium ionsXiupeng Wang, Jiandong Ye
Biomaterials Advances|October 24, 2025
Radiosensitizing in situ cancer vaccines combined with immune checkpoint blockade to overcome resistance to radioimmunotherapyXiupeng Wang, Motohiro Hirose
Colloids and Surfaces. B, Biointerfaces|April 15, 2023
Mn-Si-based nanoparticles-enhanced inhibitory effect on tumor growth and metastasis in photo-immunotherapyXueping Yu, Xiupeng Wang, Atsushi Yamazaki
Frontiers in Oncology|December 17, 2025
Antitumor efficacy of 5-aminolevulinic acid (5-ALA)-based radiodynamic therapy under single-dose X-ray irradiation in colon cancerJunko Takahashi, Shinsuke Nagasawa, Xiupeng Wang
Chemical Society Reviews|June 19, 2018
Tailoring inorganic nanoadjuvants towards next-generation vaccinesXia Li, Xiupeng Wang, Atsuo Ito
Chemical Communications (Cambridge, England)|July 4, 2020
An MRI-visible immunoadjuvant based on hollow Gd<sub>2</sub>O<sub>3</sub> nanospheres for cancer immunotherapyXia Li, Xiupeng Wang, Atsuo Ito
Pharmaceutics|April 27, 2024
Size Tuning of Mesoporous Silica Adjuvant for One-Shot Vaccination with Long-Term Anti-Tumor EffectXiupeng Wang, Yu Sogo, Xia Li
Vaccines|April 27, 2024
TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune ResponsesXiupeng Wang, Motohiro Hirose, Xia Li
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Small (Weinheim an Der Bergstrasse, Germany)|January 12, 2026
Mesoporous Silica: A Promising Adjuvant for Cancer VaccinesXiupeng Wang
Nanomaterials (Basel, Switzerland)|December 22, 2023
An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for ChemoimmunotherapyXinyuan Yuan, Xiupeng Wang
Journal of Materials Science. Materials in Medicine|August 19, 2007
Variation of crystal structure of hydroxyapatite in calcium phosphate cement by the substitution of strontium ionsXiupeng Wang, Jiandong Ye
Biomaterials Advances|October 24, 2025
Radiosensitizing in situ cancer vaccines combined with immune checkpoint blockade to overcome resistance to radioimmunotherapyXiupeng Wang, Motohiro Hirose
Colloids and Surfaces. B, Biointerfaces|April 15, 2023
Mn-Si-based nanoparticles-enhanced inhibitory effect on tumor growth and metastasis in photo-immunotherapyXueping Yu, Xiupeng Wang, Atsushi Yamazaki
Frontiers in Oncology|December 17, 2025
Antitumor efficacy of 5-aminolevulinic acid (5-ALA)-based radiodynamic therapy under single-dose X-ray irradiation in colon cancerJunko Takahashi, Shinsuke Nagasawa, Xiupeng Wang
Chemical Society Reviews|June 19, 2018
Tailoring inorganic nanoadjuvants towards next-generation vaccinesXia Li, Xiupeng Wang, Atsuo Ito
Chemical Communications (Cambridge, England)|July 4, 2020
An MRI-visible immunoadjuvant based on hollow Gd<sub>2</sub>O<sub>3</sub> nanospheres for cancer immunotherapyXia Li, Xiupeng Wang, Atsuo Ito
Pharmaceutics|April 27, 2024
Size Tuning of Mesoporous Silica Adjuvant for One-Shot Vaccination with Long-Term Anti-Tumor EffectXiupeng Wang, Yu Sogo, Xia Li
Vaccines|April 27, 2024
TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune ResponsesXiupeng Wang, Motohiro Hirose, Xia Li
Pageof 7